| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |